Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alvaro Gutierrez

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Human Molecular Genetics|June 16, 2018
Pathogenic variant in EPHB4 results in central conducting lymphatic anomalyDong Li, Tara L Wenger, Christoph Seiler, et al.
Nature Medicine|July 3, 2019
ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitorDong Li, Michael E March, Alvaro Gutierrez-Uzquiza, et al.
International Journal of Particle Therapy|September 11, 2024
Particle Beam Radiobiology Status and Challenges: A PTCOG Radiobiology Subcommittee ReportReem Ahmad, Amelia Barcellini, Kilian Baumann, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Human Molecular Genetics|June 16, 2018
Pathogenic variant in EPHB4 results in central conducting lymphatic anomalyDong Li, Tara L Wenger, Christoph Seiler, et al.
Nature Medicine|July 3, 2019
ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitorDong Li, Michael E March, Alvaro Gutierrez-Uzquiza, et al.
International Journal of Particle Therapy|September 11, 2024
Particle Beam Radiobiology Status and Challenges: A PTCOG Radiobiology Subcommittee ReportReem Ahmad, Amelia Barcellini, Kilian Baumann, et al.
Pageof 5